학술논문
First-line sintilimab with pegaspargase, gemcitabine, and oxaliplatin in advanced extranodal natural killer/T cell lymphoma (SPIRIT): a multicentre, single-arm, phase 2 trial
Document Type
Article
Author
Source
In The Lancet Haematology May 2024 11(5):e336-e344
Subject
Language
ISSN
2352-3026